Federated learning and analytics for drug discovery

Biotech companies are driving major advances in data-driven drug discovery by leveraging data sharing and collaboration.
‍
But concerns around regulatory compliance with HIPAA and GDPR and concerns with protecting valuable IP limit life science organizations' willingness to share patient data at scale, and restrict innovation.